TiUnite – the dental implant surface for enhanced osseointegration

Following the introduction of the TiUnite surface in 2000, a clear decrease in early implant failures was observed—especially in areas with poor bone density. In retrospect, that launch can be seen as an important milestone on the journey towards routine Immediate Function.

In the years since its launch by Nobel Biocare, TiUnite has be­come one of the most clinically re­searched dental implant surfaces ever brought to market.

Evidence was first accumulated, and then evaluated in more than 430 clinical publications—comprising over 21,000 patients and 82,500 implants. Compared with machined implants, TiUnite helps to maintain the implant stability achieved at placement during the critical healing phase while enhancing osseointegration and anchorage in surrounding bone.

Although it was not originally conceived nor ultimately designed with an eye towards what we now call Immediate Function, the osseointe­gration that TiUnite facilitates in the early healing phase nonetheless turns out to be of great importance when meeting patient needs for fixed im­mediate teeth.

High primary stability to support Immediate Function

In order to meet patient demand for immediate solutions dependably, the dentist must evaluate each patient’s situation conscientiously and choose the right mix of procedures and prod­ucts.

Naturally, an Immediate Function approach requires the right dental implant as well as the right protocol, if it is to offer both short and long-term success. That’s why Nobel Bio­care has developed implants and drilling protocols for high primary stability at a level that supports Immediate Function (immediate load­ing) when and wherever the clinical situation permits.

TiUnite enhanced osseointegration hemastosis

A dental implant surface for long lasting results

Clinical evidence also shows that Ti­Unite offers significant benefits not only in the period immediately after treatment, but in the long term as well. Implants with the TiUnite sur­face maintain marginal bone, both in partially and fully edentulous cases, with cumulative survival rates of 97.1– 99.2% after ten or more years—even when placed in fresh extraction sock­ets and immediately loaded.

Outcomes speak for themselves: Nobel Biocare implants are the only implants on the market to provide the moderately rough TiUnite sur­face. TiUnite has been clinically proven to enhance osseointegration compared with machined implants, allowing immediate loading proto­cols to be used more frequently and with outstanding results.

To put it simply, in order to estab­lish an enduring restoration, it’s es­sential to build on a sound founda­tion.

TiUnite enhanced osseointegration

Accelerating rate of advance

Much of the latest issue of Nobel Biocare News reflects the fact that dental im­plant patients are increasingly de­manding immediate restorations. To meet these demands, leading dental professionals such as our readers are seeking solutions with fewer surgical steps, shorter treatment time, high success rates, high patient satisfaction and function on the day of surgery.

In addition to earlier breakthrough innovations from Nobel Biocare, such as TiUnite, the All-on-4® treatment concept and zygomatic implants— just to name a few—new component and workflow enhancements from the company are further enabling im­mediate implant placement and re­ducing the time needed to deliver prosthetic teeth to dental implant pa­tients today.

Tomorrow, we’ll see treatment de­cisions being made already at the ini­tial consultation stage and consoli­dated treatment planning facilitated by computerized tools that will help to optimize every case for the best possible prosthetic outcome.


Press release, May 24, 2017

Nobel Biocare Services AG
Balz Zimmermann-Strasse 7, Kloten
T: +41 79 5700 296
E: order.switzerland@nobelbiocare.com
W: www.nobelbiocare.com